The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods...

por Bergemann, Rito, Ackermann, Elizabeth, Monia, Brett, Shenker, Andrew, Dyck, Peter
Publicado 2015

Assessing Decreased Sensation and Increased Sensory Phenomena in Diabetic Polyneuropathies

por Dyck, Peter J., Herrmann, David N., Staff, Nathan P., Dyck, P. James B.
Publicado 2013

Nerve pathologic features differentiate POEMS syndrome from CIDP

por Piccione, Ezequiel A., Engelstad, Janean, Dyck, Peter J., Mauermann, Michelle L., Dispenzieri, Angela, Dyck, P. James B.
Publicado 2016

Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy

por Adams, David, Suhr, Ole B., Dyck, Peter J., Litchy, William J., Leahy, Raina G., Chen, Jihong, Gollob, Jared, Coelho, Teresa
Publicado 2017

Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia

por Klein, Christopher J, Wu, Yanhong, Kilfoyle, Dean H, Sandroni, Paola, Davis, Mark D, Gavrilova, Ralitza H, Low, Phillip A, Dyck, Peter J
Publicado 2013

Vasculitic neuropathy following exposure to minocycline

por Baratta, John M., Dyck, P. James B., Brand, Patricio, Thaisetthawatkul, Pariwat, Dyck, Peter J., Engelstad, JaNean K., Goodman, Brent, Karam, Chafic
Publicado 2015

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

por Tesfaye, Solomon, Boulton, Andrew J.M., Dyck, Peter J., Freeman, Roy, Horowitz, Michael, Kempler, Peter, Lauria, Giuseppe, Malik, Rayaz A., Spallone, Vincenza, Vinik, Aaron, Bernardi, Luciano, Valensi, Paul
Publicado 2010

Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

por Ziegler, Dan, Low, Phillip A., Litchy, William J., Boulton, Andrew J.M., Vinik, Aaron I., Freeman, Roy, Samigullin, Rustem, Tritschler, Hans, Munzel, Ullrich, Maus, Joachim, Schütte, Klemens, Dyck, Peter J.
Publicado 2011

SUN-381 Cortical Porosity Is Associated with Peripheral Small Vessel Disease in Adult Patients with Type 2 Diabetes

por Samakkarnthai, Parinya, Sfeir, Jad G, Wennberg, Paul W, Dyck, Peter J, Achenbach, Sara J, Atkinson, Elizabeth J, Tweed, Amanda J, Volkman, Tammie L, Drake, Matthew T, Farr, Joshua N, Khosla, Sundeep
Publicado 2020

Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus

por Shelly, Shahar, Shouman, Kamal, Paul, Pritikanta, Engelstad, JaNean, Amrami, Kimberly K., Spinner, Robert J., Dubey, Divyanshu, Vazquez Do Campo, Rocio, Dyck, Peter J., Klein, Christopher J., Dyck, P. James B.
Publicado 2021

mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin‐mediated amyloidosis

por Dyck, P. James B., Kincaid, John C., Wiesman, Janice F., Polydefkis, Michael, Litchy, William J., Mauermann, Michelle L., Ackermann, Elizabeth J., Guthrie, Spencer, Pollock, Michael, Jung, Shiangtung W., Baker, Brenda F., Dyck, Peter J.
Publicado 2020

Impaired Glycemia and Diabetic Polyneuropathy: The OC IG Survey

por Dyck, Peter J., Clark, Vicki M., Overland, Carol J., Davies, Jenny L., Pach, John M., Dyck, P. James B., Klein, Christopher J., Rizza, Robert A., Melton, L. Joseph, Carter, Rickey E., Klein, Ronald, Litchy, William J.
Publicado 2012

Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis

por Dyck, P. James B., Coelho, Teresa, Waddington Cruz, Marcia, Brannagan, Thomas H., Khella, Sami, Karam, Chafic, Berk, John L., Polydefkis, Michael J., Kincaid, John C., Wiesman, Janice F., Litchy, William J., Mauermann, Michelle L., Ackermann, Elizabeth J., Baker, Brenda F., Jung, Shiangtung W., Guthrie, Spencer, Pollock, Michael, Dyck, Peter J.
Publicado 2020

Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L(Rx) (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneu...

por Coelho, Teresa, Ando, Yukio, Benson, Merrill D., Berk, John L., Waddington-Cruz, Márcia, Dyck, Peter J., Gillmore, Julian D., Khella, Sami L., Litchy, William J., Obici, Laura, Monteiro, Cecilia, Tai, Li-Jung, Viney, Nicholas J., Buchele, Gustavo, Brambatti, Michela, Jung, Shiangtung W., St. L. O’Dea, Louis, Tsimikas, Sotirios, Schneider, Eugene, Geary, Richard S., Monia, Brett P., Gertz, Morie
Publicado 2021

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update

por Brannagan, Thomas H., Coelho, Teresa, Wang, Annabel K., Polydefkis, Michael J., Dyck, Peter J., Berk, John L., Drachman, Brian, Gorevic, Peter, Whelan, Carol, Conceição, Isabel, Plante-Bordeneuve, Violaine, Merlini, Giampaolo, Obici, Laura, Plana, Josep Maria Campistol, Gamez, Josep, Kristen, Arnt V., Mazzeo, Anna, Gentile, Luca, Narayana, Arvind, Olugemo, Kemi, Aquino, Peter, Benson, Merrill D., Gertz, Morie
Publicado 2022

Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss

por Klein, Christopher J., Botuyan, Maria-Victoria, Wu, Yanhong, Ward, Christopher J., Nicholson, Garth A., Hammans, Simon, Hojo, Kaori, Yamanishi, Hiromitch, Karpf, Adam R., Wallace, Douglas C., Simon, Mariella, Lander, Cecilie, Boardman, Lisa A., Cunningham, Julie M., Smith, Glenn E., Litchy, William J., Boes, Benjamin, Atkinson, Elizabeth J., Middha, Sumit, Dyck, P. James, Parisi, Joseph E., Mer, Georges, Smith, David I., Dyck, Peter J.
Publicado 2011